The peptide market is experiencing unprecedented growth as compounds previously available only through gray-market channels gain legitimacy. Regulatory frameworks are evolving to accommodate mainstream distribution of these bioactive molecules, transforming underground markets into regulated industries. This shift reflects growing scientific validation of peptide therapeutics and increasing consumer demand for performance optimization and health enhancement solutions.

Summary auto-generated by AI from the original publisher's content. Editorial standards.